Another study, conducted by Afroditi Nonni’s group, also examined the expression of HDAC2 in 118 deceased sporadic BC patients and its correlation with clinicopathological characteristics of the tumor and the prognosis of the patient. This evidence concerns the gene HDAC2 and breast cancer.